[go: up one dir, main page]

CA2400643A1 - Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use - Google Patents

Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use Download PDF

Info

Publication number
CA2400643A1
CA2400643A1 CA002400643A CA2400643A CA2400643A1 CA 2400643 A1 CA2400643 A1 CA 2400643A1 CA 002400643 A CA002400643 A CA 002400643A CA 2400643 A CA2400643 A CA 2400643A CA 2400643 A1 CA2400643 A1 CA 2400643A1
Authority
CA
Canada
Prior art keywords
region
seq
hcv
spanning
epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002400643A
Other languages
English (en)
French (fr)
Inventor
Geert Maertens
Fons Bosman
Erik Depla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GenImmune NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2400643A1 publication Critical patent/CA2400643A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002400643A 2001-01-11 2002-01-11 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use Abandoned CA2400643A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26066901P 2001-01-11 2001-01-11
US60/260,699 2001-01-11
US31576801P 2001-08-30 2001-08-30
US60/315,768 2001-08-30
PCT/EP2002/000219 WO2002055548A2 (en) 2001-01-11 2002-01-11 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use

Publications (1)

Publication Number Publication Date
CA2400643A1 true CA2400643A1 (en) 2002-07-18

Family

ID=26948130

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002400643A Abandoned CA2400643A1 (en) 2001-01-11 2002-01-11 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use

Country Status (16)

Country Link
EP (1) EP1463753A2 (pt)
KR (1) KR20020089371A (pt)
CN (1) CN1547588A (pt)
AR (1) AR032240A1 (pt)
AU (1) AU2002238502B2 (pt)
BR (1) BR0203518A (pt)
CA (1) CA2400643A1 (pt)
CZ (1) CZ20032164A3 (pt)
HU (1) HUP0302416A2 (pt)
IL (1) IL151033A0 (pt)
MX (1) MXPA02008886A (pt)
NO (1) NO20024325L (pt)
PL (1) PL363175A1 (pt)
RU (1) RU2313363C2 (pt)
TR (1) TR200202169T1 (pt)
WO (1) WO2002055548A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002086101A2 (en) 2001-04-24 2002-10-31 Innogenetics N.V. Core-glycosylated hcv envelope proteins
AU2003283365A1 (en) * 2002-11-08 2004-06-07 Innogenetics N.V. HCV vaccine compositions comprising E1 and NS3 peptides
EP1561470A1 (en) * 2003-06-20 2005-08-10 Innogenetics N.V. HCV vaccines comprising the envelope-1 (E1) protein or the corresponding DNA and at least one antiviral agent
EP2267004A3 (en) * 2003-09-22 2011-04-27 Green Peptide Co., Ltd. Peptide derived from hepatitis C virus
CN100365124C (zh) * 2005-10-27 2008-01-30 云南大学 一段丙型肝炎病毒特异性cDNA序列的应用
CN115980352A (zh) * 2022-12-30 2023-04-18 宁波博肽生物技术有限公司 一种hcv抗原包被预处理剂、抗原包被方法及检测试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG71728A1 (en) * 1994-07-29 2000-04-18 Innogenetics Nv Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use

Also Published As

Publication number Publication date
RU2313363C2 (ru) 2007-12-27
MXPA02008886A (es) 2003-04-25
RU2002121632A (ru) 2004-03-20
IL151033A0 (en) 2003-04-10
WO2002055548A8 (en) 2002-10-31
CZ20032164A3 (cs) 2003-10-15
PL363175A1 (en) 2004-11-15
EP1463753A2 (en) 2004-10-06
CN1547588A (zh) 2004-11-17
NO20024325D0 (no) 2002-09-10
HUP0302416A2 (hu) 2003-10-28
AU2002238502B2 (en) 2007-09-06
WO2002055548A2 (en) 2002-07-18
KR20020089371A (ko) 2002-11-29
WO2002055548A3 (en) 2004-08-05
AU2002238502A1 (en) 2002-07-24
BR0203518A (pt) 2002-12-17
AU2002238502B9 (en) 2002-07-24
TR200202169T1 (tr) 2004-06-21
AR032240A1 (es) 2003-10-29
NO20024325L (no) 2002-11-11

Similar Documents

Publication Publication Date Title
EP0721505B2 (en) Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
US7101561B2 (en) Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
AU2002361160B2 (en) Purified Hepatitis C virus envelope proteins for diagnostic and therapeutic use
AU2002238502B9 (en) Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
US20040126395A1 (en) Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
US7108855B2 (en) Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
US20030095980A1 (en) Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
AU757962B2 (en) Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
NZ521299A (en) Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
AU708174B2 (en) Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
ZA200207272B (en) Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use.
JP2004525885A (ja) 診断用および治療用の精製c型肝炎ウイルスエンベロープタンパク質
ZA200405218B (en) Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use.

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued